Skip to main content
SpringerLink
Log in

Financial Hardship

  • Chapter
  • First Online:
Handbook of Cancer Survivorship

Abstract

The cost of cancer care has increased rapidly during the last decade, and accumulating evidence indicates that cancer survivors are at a higher risk for experiencing financial hardship than persons without a history of cancer. Cancer survivors are also at increased risk for developing additional cancers and other chronic conditions, and treatment for those conditions can cause immediate or delayed side effects. These effects can limit the ability to work and reduce household income. Work limitations might also reduce employment-based health insurance options, magnifying the financial impact of cancer. This chapter provides an overview of financial hardship among cancer survivors. We describe a typology of financial hardship and its basic domains: material conditions, psychological response, and coping behaviors. We then summarize current knowledge and identify important topics for future efforts in research and practice with the goal of minimizing financial hardship among cancer survivors and their families.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bradley CJ, Yabroff KR, Warren JL, Zeruto C, Chawla N, Lamont EB. Trends in the treatment of metastatic colon and rectal cancer in elderly patients. Med Care. 2016;54(5):490–7.

    Article  Google Scholar 

  2. Shih YC, Smieliauskas F, Geynisman DM, Kelly RJ, Smith TJ. Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol. 2015;33(19):2190–6.

    Article  Google Scholar 

  3. Conti RM, Fein AJ, Bhatta SS. National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011. Health Aff (Millwood). 2014;33(10):1721–7.

    Article  Google Scholar 

  4. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol. 2007;25(2):180–6.

    Article  Google Scholar 

  5. Bach PB. Limits on Medicare’s ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626–33.

    Article  CAS  Google Scholar 

  6. Bach PB. Costs of cancer care: a view from the centers for Medicare and Medicaid services. J Clin Oncol. 2007;25(2):187–90.

    Article  Google Scholar 

  7. Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomark Prev. 2011;20(10):2006–14.

    Article  Google Scholar 

  8. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2006;366(9503):2087–106.

    Google Scholar 

  9. Oeffinger KC, Mertens AC, Sklar CA, Kawashima MS, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.

    Article  CAS  Google Scholar 

  10. De Boer AGEM, Taskila T, Ojajarvi A, van Dijk FJ, Verbeek JH. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62.

    Article  Google Scholar 

  11. Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst. 2017;109(2):pii:djw205.

    Article  Google Scholar 

  12. American Cancer Society [Internet]. Atlanta. Cancer Treatment & Survivorship Facts & Figures 2016–2017. Atlanta: American Cancer Society; 2016. [cited 2016 Nov 12]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2016-2017.pdf.

  13. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117–28.

    Article  Google Scholar 

  14. The State of Cancer Care in America, 2015: a report by the American Society of Clinical Oncology. J Oncol Pract. 2015;11(2):79–113.

    Google Scholar 

  15. Howard DH, Bach PB, Ernst RB, Conti RM. Pricing in the market for anticancer drugs. J Econ Perspect. 2015;29(1):139–62.

    Article  Google Scholar 

  16. Bach PB. Why drugs cost so much. New York Times. 14 Jan 2015.

    Google Scholar 

  17. Young RA, DeVoe JE. Who will have health insurance in the future? An updated projection. Ann Fam Med. 2012;10(2):156–62.

    Article  Google Scholar 

  18. Tucker-Seeley RD, Yabroff KR. Minimizing the “financial toxicity” associated with cancer care: advancing the research agenda. J Natl Cancer Inst. 2016;108(5).

    Article  Google Scholar 

  19. de Souza JA, Yap BJ, Ratain MJ, Daughtery C. User beware: we need more science and less art when measuring financial toxicity in oncology. J Clin Oncol. 2015;33(12):1414–5.

    Article  Google Scholar 

  20. Norredam M, Meara E, Landrum MB, Huskamp HA, Keating NL. Financial status, employment, and insurance among older cancer survivors. J Gen Intern Med. 2009;24(Suppl 2):S438–45.

    Article  Google Scholar 

  21. Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–149.

    Google Scholar 

  22. Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient. 2016;10(3):295–309.

    Article  Google Scholar 

  23. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18(4):381–90.

    Article  Google Scholar 

  24. Martin MY, Fouad MN, Oster RA, Schrag D, Urmie J, Sanders S, et al. What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups. Support Care Cancer. 2014;22(1):233–44.

    Article  Google Scholar 

  25. Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2014;2(3):271–8.

    Google Scholar 

  26. Regenbogen SE, Veenstra CM, Hawley ST, Banerjee M, Ward KC, Kato I, et al. The personal financial burden of complications after colorectal cancer surgery. Cancer. 2014;120(19):3074–81.

    Article  Google Scholar 

  27. Dussel V, Bona K, Heath JA, Hilden JM, Weeks JC, Wolfe J. Unmeasured costs of a child’s death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. J Clin Oncol. 2011;29(8):1007–13.

    Article  Google Scholar 

  28. Timmons A, Gooberman-Hill R, Sharp L. “It’s at a time in your life when you are most vulnerable”: a qualitative exploration of the financial impact of a cancer diagnosis and implications for financial protection in health. PLoS One. 2013;8(11):e77549.

    Article  CAS  Google Scholar 

  29. Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013;32(6):1143–52.

    Article  Google Scholar 

  30. Guy GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31(30):3749–57.

    Article  Google Scholar 

  31. Guy GP, Yabroff KR, Ekwueme DU, Virgo KS, Han X, Banegas MP, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008–2012. Am J Prev Med. 2015;6(49):S489–97.

    Article  Google Scholar 

  32. Davidoff AJ, Erten M, Shaffer T, Shoemaker JS, Zuckerman IH, Pandya N, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6):1257–65.

    Article  Google Scholar 

  33. Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821–6.

    Article  Google Scholar 

  34. Baili P, Di Salvo F, de Lorenzo F, Maietta F, Pinto C, Rizzotto V, et al. Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study. Support Care Cancer. 2016;24(5):2225–33.

    Article  Google Scholar 

  35. Gordon LG, Walker SM, Mervin MC, Low A, Smith DP, Gardiner RA, et al. Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. Eur J Cancer Care. 2015;26(1):1–10.

    Google Scholar 

  36. Mahal A, Karan A, Fan VY, Engelgau M. The economic burden of cancers on Indian households. PLoS One. 2013;8(8):e71853.

    Article  CAS  Google Scholar 

  37. de Oliveira C, Bremmer K, Ni A, Alibhai SMH, Laport A, Krahn MD. Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada. J Cancer Surviv. 2014;8(1):9–20.

    Article  Google Scholar 

  38. Jan S, Kimman M, Peters SA, Woodward M. Financial catastrophe, treatment discontinuation and death associated with surgically operable cancer in South-East Asia: results from the ACTION Study. Surgery. 2015;157(6):971–82.

    Article  Google Scholar 

  39. Kimman M, Jan S, Yip CH, Thabray H, Peters SA, Bhoo-Pathy N, et al. Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries. BMC Med. 2015;13:190.

    Article  Google Scholar 

  40. Lauzier S, Levesque P, Mondor M, Drolet M, Coyle D, Brisson J, et al. Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses. J Natl Cancer Inst. 2013;105(4):280–92.

    Article  Google Scholar 

  41. Wan Y, Gao X, Mehta S, Wang Z, Faria C, Schwartzberg L. Indirect costs associated with metastatic breast cancer. J Med Econ. 2013;16(10):1169–78.

    Article  Google Scholar 

  42. Finkelstein EA, Tangka F, Trogdon JG, Sabatino SA, Richardson LC. The personal financial burden of cancer for the working-aged population. Am J Manag Care. 2009;15(11):801–6.

    PubMed  Google Scholar 

  43. Ekwueme DU, Yabroff KR, Guy GP, Banegas MP, de Moor JS, Li C, et al. Medical costs and productivity losses of cancer survivors—United States, 2008–2011. MMWR Morb Mortal Wkly Rep. 2014;63(23):505–10.

    PubMed  PubMed Central  Google Scholar 

  44. Hanly PA, Sharp L. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer. 2014;14(1):224.

    Article  Google Scholar 

  45. Hanly PA, Soerjomataram I, Sharp L. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer. 2015;136(4):E136–45.

    Article  CAS  Google Scholar 

  46. Cagle JG, Carr DC, Hong S, Zimmerman S. Financial burden among US households affected by cancer at the end of life. Psycho-Oncology. 2016;25(8):919–26.

    Article  Google Scholar 

  47. Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2(10):e408–16.

    Article  Google Scholar 

  48. Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269–76.

    Article  Google Scholar 

  49. Banegas MP, Guy GP, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff (Millwood). 2016;35(1):54–61.

    Article  Google Scholar 

  50. Veenstra CM, Regenbogen SE, Hawley ST, Griggs JJ, Banerjee M, Kato I, et al. A composite measure of personal financial burden among patients with stage III colorectal cancer. Med Care. 2014;52(11):957–62.

    Article  Google Scholar 

  51. Zafar S, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2015;11(2):145–50.

    Article  Google Scholar 

  52. Meisenberg BR, Varner A, Ellis E, Ebner S, Moxley J, Siegrist E, et al. Patient attitudes regarding the cost of illness in cancer care. Oncologist. 2015;20(10):1199–204.

    Article  Google Scholar 

  53. Meneses K, Azuero A, Hassey L, McNees P, Pisu M. Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol. 2012;124(3):437–43.

    Article  Google Scholar 

  54. Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608–14.

    Article  Google Scholar 

  55. Yabroff KR, Dowling EC, Gery GP, Banegas MP, Davidoff A, Han X, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259–67.

    Article  Google Scholar 

  56. Ell K, Xie B, Wells A, Nedjat-Haiem F, Lee P, Vourlekis B. Economic stress among low-income women with cancer: effects on quality of life. Cancer. 2008;112(3):616–25.

    Article  Google Scholar 

  57. Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psycho-Oncology. 2013;22(4):745–55.

    Article  Google Scholar 

  58. Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014;10(3):162–7.

    Article  Google Scholar 

  59. Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119(20):3710–7.

    Article  Google Scholar 

  60. Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504.

    Article  Google Scholar 

  61. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32(4):306–11.

    Article  Google Scholar 

  62. Farias AJ, Du XL. Association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy adherence among Medicare patients with breast cancer. J Clin Oncol. 2017;35(1):86–95.

    Article  Google Scholar 

  63. Streeter SB, Schwartzberg L, Husain N, Johnsrud M. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 2011;7(3 Suppl):46s–51s.

    Article  Google Scholar 

  64. Zheng Z, Han X, Guy GP, Davidoff AJ, Li C, Banegas MP, et al. Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States. Cancer. 2017;

    Google Scholar 

  65. Zafar SY. Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Inst. 2016;108(5)

    Google Scholar 

  66. McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health pro-motion programs. Health Educ Q. 1988;15:351–77.

    Article  CAS  Google Scholar 

  67. Dowling EC, Chawla N, Forsythe LP, de Moor J, McNeel T, Rozjabek HM, et al. Lost productivity and burden of illness in cancer survivors with and without chronic conditions. Cancer. 2013;119(18):3393–401.

    Article  Google Scholar 

  68. Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011;29(18):2534–42.

    Article  Google Scholar 

  69. Cost of Cancer Care [Internet]. The University of Chicago. [cited 2017 September 24]. Available from https://costofcancercare.uchicago.edu/.

  70. Patient Advocate Foundation [Internet]. Patient Advocate Foundation Resources. [cited 2017 October 20]. Available from: http://www.patientadvocate.org/resources.php.

  71. HealthWell Foundation [Internet]. Emergency Cancer Relief Fund. [cited 2017 October 20]. Available from: https://www.healthwellfoundation.org/what-we-do/emergency-cancer-relief-fund/.

  72. Cancer Financial Assistance Coalition [Internet]. Cancer Financial Assistance Coalition Database. [cited 2017 October 24]. Available from: www.cancerfac.org.

  73. Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85(1):114–24.

    Article  Google Scholar 

  74. Christie J, Itzkowitz S, Lihau-Nkanza I, Castillo A, Redd W, Jandorf L. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc. 2008;100(3):278–84.

    Article  Google Scholar 

  75. Irwin B, Kimmick G, Altomare I, Marcom PK, Houck K, Zafar SY, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014;19(11):1135–40.

    Article  Google Scholar 

  76. Schrag D, Hanger M. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol. 2007;25(2):233–7.

    Article  Google Scholar 

  77. Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, et al. Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received. J Clin Oncol. 2016;34(24):2925–34.

    Article  Google Scholar 

  78. Robert Wood Johnson Foundation [Internet]. Costs of Care: Getting the Patient-Provider Conversation Right. [cited 2017 October 20]. Available from: https://www.rwjf.org/en/culture-of-health/2016/06/costs_of_care_getti.html.

  79. Warsame RM, Thompson CA, Hubbard JM, Fonder AL, Hobbs MA, Hwa L, et al. What are patients’ biggest concerns? A patient reported outcome case-management system. J Clin Oncol. 2017;(35):S15. Abstr 6572

    Google Scholar 

  80. Han X, Zang XK, Kramer MR, Jemal H. The affordable care act and cancer stage at diagnosis among young adults. J Natl Cancer Inst. 2016;108(9):djw058.

    Article  Google Scholar 

  81. Robbins AS, Han X, Ward EM, Simard EP, Zheng Z, Jemal A. Association between the affordable care act dependent coverage expansion and cervical cancer stage and treatment in young women. JAMA. 2015;314(20):2189–91.

    Article  CAS  Google Scholar 

  82. Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980–6.

    Article  CAS  Google Scholar 

  83. About EQ-5D-5L [Internet]. EQ-5D [cited 2017 May 6]. Available from: http://www.euroqol.org/eq-5d-5l-about.html.

  84. Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol. 2016;34(15):1732–40.

    Article  CAS  Google Scholar 

  85. Delgado-Guay M, Ferrer J, Rieber AG, Rhondali W, Tayjasanant S, Ochoa J, et al. Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist. 2015;20(9):1092–8.

    Article  Google Scholar 

  86. Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, et al. Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract. 2014;10(5):332–8.

    Article  Google Scholar 

  87. Kale HP, Carroll NV. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer. 2016;122(8):283–9.

    Article  Google Scholar 

  88. Chino F, Peppercorn J, Taylor DH, Lu Y, Samsa G, Abernethy AP, et al. Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist. 2014;19(4):414–20.

    Article  Google Scholar 

  89. Prawitz AD, Garman ET, Sorhaindo B, O’Neill B, Kim J, Drentea P, et al. InCharge financial distress/financial well-being scale: development, administration, and score interpretation. J Finan Counsel Plann. 2006;17:34–50.

    Google Scholar 

  90. de Souza JA, Yap BJ, Hlubokcy FJ, Wroblewski K, Ratain MJ, Cella D, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120:3245–53.

    Article  Google Scholar 

  91. National Center for Health Statistics [Internet]. Survey Description National Health Interview Survey (NHIS) Public Use Data Release 2014 [cited 2017 Jan 20]. Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2014/srvydesc.pdf.

  92. Agency for Healthcare Research and Quality [Internet]. Medical Expenditure Panel Sur-vey [cited 2017 March 2]. Available from: http://www.meps.ahrq.gov/mepsweb/.

  93. National Cancer Institute [Internet]. Financial toxicity and cancer treatment (PDQ) – Health Professional Version: Evidence Gaps and Areas for Future Research [cited 2017 February 12]. Available from: https://www.cancer.gov/about-cancer/managing-care/financial-toxicity-hp-pdq.

  94. Nekhlyudov L, Ganz PA, Arora N, Rowland J. Going beyond being lost in transition: a decade of progress in cancer survivorship. J Clin Oncol. 2017;35:1978. Epub 2017 Jun 20;35(18):1978–1981.

    Article  Google Scholar 

  95. Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition: Washington, D.C., The National Academies Press; 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services, Atlanta, GA, USA

    Sarah E. Lewis

  2. National Cancer Institute, Rockville, MD, USA

    Maryam Doroudi

  3. Surveillance & Health Services Research, American Cancer Society, Inc, Atlanta, GA, USA

    K. Robin Yabroff

Authors
  1. Sarah E. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Doroudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Robin Yabroff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah E. Lewis .

Editor information

Editors and Affiliations

  1. Professor (ret), Uniformed Services University Founder, Editor in Chief, Journal of Cancer Survivorship: Research and Practice, Bethesda, MD, USA

    Michael Feuerstein

  2. Department of Medicine, Brigham & Women’s Hospital, Perini Family Survivors’ Center, Dana-Farber Cancer Institute, Boston, MA, USA

    Larissa Nekhlyudov

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lewis, S.E., Doroudi, M., Robin Yabroff, K. (2018). Financial Hardship. In: Feuerstein, M., Nekhlyudov, L. (eds) Handbook of Cancer Survivorship. Springer, Cham. https://doi.org/10.1007/978-3-319-77432-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-77432-9_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-77430-5

  • Online ISBN: 978-3-319-77432-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation